Maximum citalopram dose reduced

Citalopram is associated with dose-dependent QT interval prolongation | SCIENCE PHOTO LIBRARY
Citalopram is associated with dose-dependent QT interval prolongation | SCIENCE PHOTO LIBRARY

The maximum daily dose of citalopram has been reduced from 60mg to 40mg owing to the risk of dose-dependent QT interval prolongation. In the elderly and in patients with reduced hepatic function, the maximum dose is lowered to 20mg daily.

ECG monitoring revealed a dose-dependent prolongation of the QT interval in healthy patients taking citalopram. Patients with underlying heart conditions and those who are predisposed to hypokaleamia or hypomagnesaemia are particularly at risk of QT interval prolongation.

Cases of ventricular arrhythmia including torsade de pointes have also been identified in citalopram-treated patients.

Other studies have not shown an additional benefit of citalopram at doses higher than 40mg daily in the treatment of depression. Citalopram is now contraindicated in patients with known QT interval prolongation or congenital long QT syndrome.

Patients who are on higher doses will need to be identified, reviewed and doses gradually reduced.

Cases of QT interval prolongation have also been reported with other SSRIs including escitalopram (Cipralex).

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases